Japan Pharmaceuticals News
Japan
Japan Pharmaceuticals News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about Japan Pharmaceuticals.
Latest Japan Pharmaceuticals News
- Alligator Bioscience Awarded New Patent for its Protein Optimization Technology FIND® in Japan 6 Dec 2009 17:35 GMT
... protein optimization company, today announces that the Japan Patent Office has granted the patent application ... pipeline of novel and improved versions of biopharmaceuticals. We focus on candidates in inflammation and ... importance for our future development on the Japanese market." About FIND® FIND® is a rapid ...
- Memories fresh 68 years later for Pearl Harbor survivor 6 Dec 2009 22:40 GMT
... With the Great Depression winding down in the late 1930s, ... bunk aboard the USS Raleigh when the Japanese attacked Pearl Harbor. The Raleigh was struck ... They met by chance in a Bridgeton drug store, and married the next week. She died ...
- A look at the P. Harbor memories of celebrities 6 Dec 2009 14:42 GMT
... A look at the P. Harbor memories of celebrities By Candace ... memory of Dec. 7, 1941, the day Japan attacked Pearl Harbor. Thus began Barrett's 23-year ... reached the corner where the famed Schwab's Drugstore was ... We began to notice people ...
- Oil And Gas Driven Industrialization 6 Dec 2009 05:10 GMT
... (i) petrochemical industry targeting plastic products and pharmaceuticals (ii) exploitation of important natural resources such ... an oil exporter and actually exported to Japan for more than 25 years since 1974. ... was two-thirds of Japan’s imports. Similarly, the Japanese government is supporting Japanese oil companies to ...
- Researchers Report Clinical Association Between Type II PNH Cells and Thrombocytopenia 6 Dec 2009 15:24 GMT
... accounts for 18 percent of deaths among Japanese patients with PNH. (6) PNH has been ... information on PNH is available at Alexion Pharmaceuticals, Inc. is a biopharmaceutical company working to ... nocturnal hemoglobinuria in the United States and Japan. 7. Wang H, Chuhjo T, Yasue S, ...
- VELCADE (Bortezomib) for Injection Based Regimens Result in Lower Costs and Less Patient Burden Than Other Commonly Used 6 Dec 2009 03:30 GMT
... study co-author and Associate Director in the Pharmaceutical Outcomes Research and Policy Program, Department of ... Pharmaceutical K.K. is responsible for commercialization in Japan. VELCADE is approved in more than 87 ...
- VELCADE(R) (Bortezomib) for Injection Based Regimens Result in Lower Costs and Less Patient Burden Than Other Commonly Used Multiple Myeloma Treatment Regimens 6 Dec 2009 03:31 GMT
... study co-author and Associate Director in the Pharmaceutical Outcomes Research and Policy Program, Department of ... Pharmaceutical K.K. is responsible for commercialization in Japan. VELCADE is approved in more than 87 ...
- VELCADE® (Bortezomib) for Injection Based Regimens Result in Lower Costs and Less Patient Burden Than Other Commonly Used Multiple Myeloma Treatment Regimens 6 Dec 2009 03:31 GMT
... study co-author and Associate Director in the Pharmaceutical Outcomes Research and Policy Program, Department of ... Pharmaceutical K.K. is responsible for commercialization in Japan. VELCADE is approved in more than 87 ...
- VELCADE® (Bortezomib) for Injection Based Regimens Result in Lower Costs and Less Patient Burden Than 6 Dec 2009 05:35 GMT
... study co-author and Associate Director in the Pharmaceutical Outcomes Research and Policy Program, Department of ... Pharmaceutical K.K. is responsible for commercialization in Japan. VELCADE is approved in more than 87 ...
- Life Sciences: Research findings from University of Toyama update understanding of life sciences 6 Dec 2009 05:35 GMT
... Andoh, University of Toyama, Dept. of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, ... of Medicine and Pharmaceutical Sciences, Toyama 930-1094, Japan. can be contacted at: Nature Publishing Group, ...
- In the Region | Long Island: Downtown, Living Upstairs 6 Dec 2009 03:14 GMT
... LIVING over a store has sometimes been a tad ... within walking distance of a Dunkin' Donuts, Japanese and Chinese restaurants, several coffee shops, a CVS drugstore, his tax preparer and his doctors' offices. ...
- VELCADE(R) (Bortezomib) for Injection Based Regimens Result in Lower Costs and Less Patient Burden Than Other Commonly Used Multiple Myeloma Treatment Regimens (BIZ) 6 Dec 2009 03:34 GMT
... over 45,000 deaths annually. Johnson & Johnson Pharmaceutical Research & Development , L.L.C., and approved ... Pharmaceutical K.K. is responsible for commercialization in Japan. VELCADE is approved in more than 87 ...
- Watson challenges Takeda's Rozerem patent 6 Dec 2009 04:35 GMT
... MORRISTOWN, N.J. (AP) - Watson Pharmaceuticals Inc. said Friday it is challenging Takeda ... Rozerem, prior to the drug's patent expiration. Japan-based Takeda filed a lawsuit against Watson on ...
- Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcomi 6 Dec 2009 17:35 GMT
... 90 countries, including the US, EU and Japan, for the treatment of all phases of ... meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health ...
- Market Report: Global Biotechnology market forecast to have a value of $305.7 billion by 2013 6 Dec 2009 19:45 GMT
... chapters on 5 major markets (France, Germany, Japan, the UK and the US). * Includes ... & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. ...
- Aqua-farmers trying to bring kelp into mainstream 6 Dec 2009 05:50 GMT
... soups, garnishes, snacks and with sushi in Japan. Kelp is processed to extract food gums, ... Logan neighborhood processed it for food additives, pharmaceuticals, chemicals and other industries. Energy activists pushed ...
- New Colorectal Cancer Screening Combination Increases Detection by 10 Percent 6 Dec 2009 06:53 GMT
... University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, and lead author of the study. ... and risks. In a study conducted in Japan, doctors analyzed data from 21,794 asymptomatic persons ...
- Cytokinetics Announces Clinical Trial Data Regarding SB-743921 Presented at the 2009 American Society of Hematology Annual Meeting and Exposition 6 Dec 2009 16:30 GMT
... The secondary objectives were to characterize the pharmacokinetics of SB-743921 administered on this schedule and ... Inc. holds an exclusive license worldwide (excluding Japan) to develop and commercialize omecamtiv mecarbil and ...
- Cytokinetics Announces Clinical Trial Data Regarding SB-743921 Presented at the 2009 American Societ 6 Dec 2009 16:36 GMT
... The secondary objectives were to characterize the pharmacokinetics of SB-743921 administered on this schedule and ... Inc. holds an exclusive license worldwide (excluding Japan) to develop and commercialize omecamtiv mecarbil and ...
- Cytokinetics Announces Clinical Trial Data Regarding SB-743921 Presented at the 2009 American Society of Hematology Annu 6 Dec 2009 16:41 GMT
... The secondary objectives were to characterize the pharmacokinetics of SB-743921 administered on this schedule and ... Inc. holds an exclusive license worldwide (excluding Japan) to develop and commercialize omecamtiv mecarbil and ...
- Cytokinetics Announces Clinical Trial Data Regarding SB-743921 Presented at the 2009 American Society of Hematology Annual Meeting and Exposition (MRW) 6 Dec 2009 16:50 GMT
... The secondary objectives were to characterize the pharmacokinetics of SB-743921 administered on this schedule and ... failure. holds an exclusive license worldwide (excluding Japan) to develop and commercialize omecamtiv mecarbil and ...
- Cytokinetics Announces Clinical Trial Data Regarding SB-743921 Presented at the 2009 American Society of Hematology 6 Dec 2009 16:54 GMT
... The secondary objectives were to characterize the pharmacokinetics of SB-743921 administered on this schedule and ... Inc. holds an exclusive license worldwide (excluding Japan) to develop and commercialize omecamtiv mecarbil and ...
- Nplate(R) Data From MDS Studies Presented at ASH 6 Dec 2009 18:50 GMT
... (2003), the EU (2005), Switzerland (2005) and Japan (2006). Nplate is the first treatment specifically ... containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations ...
- Newly published market report: Sports Equipment in the United States 6 Dec 2009 19:59 GMT
... the United Kingdom. Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan. Report ... & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. ...
- Nplate(R) Data From MDS Studies Presented at ASH 6 Dec 2009 19:59 GMT
... (2003), the EU (2005), Switzerland (2005) and Japan (2006). Nplate is the first treatment specifically ... containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations ...
Powered by 
Japan Pharmaceuticals News Sections
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Pharmaceutical Industry Today
|
a digital news provider
ap.org:
cnn.com:
bbc.co.uk:
healthday.com: